CHRU Nancy
Vandœuvre-lès-Nancy, 54500, France
Location status: Recruiting
NCT Number: NCT04937751
In recent decades, invasive fusarioses have been emerging fungal pathologies with high mortality. The prognosis depends on the speed of the diagnosis, but currently biological diagnosis is mainly based on fungal culture, no specific biomarker for this microorganism is available in current clinical practice. The genus Fusarium also shows reduced sensitivity to antifungals commonly used and recommended in clinical practice, such as voriconazole or amphotericin B.
The main objective of this study is to describe the proportions of different fungal species in positive fungal cultures in patients with invasive fungal infection (IFI) or fungal keratitis. The secondary objectives are the description of the dosage of galactomannans, beta (1,3) -D-glucans and the rate of detection of DNA circulating in case / control groups for the 2 clinical forms studied. In patients with evidence of Fusarium wilt, the study will describe the distribution of the different minimum inhibitory concentrations (MIC) depending on whether or not different antifungals are taken, the vital status at 3 months, and the response or not to treatment. Finally, the presence of genetic markers will be described according to the groups of MIC values.
Interested in participating?
Request InfoAll sexes
Observational
Vandœuvre-lès-Nancy, 54500, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
galactomannan, betaDglucan, resistance markers
Time frame: 2021-2026
Central Hospital, Nancy, France
Other
Multicenter Study on Invasive Fusariosis : Looking for Markers of Infection and Resistance
Acronym: FUSIMIR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02714504
Bacterial Infections and Mycoses, Dermatomycoses
Rio de Janeiro, Brazil
View Trial DetailsNCT00518778
Bacterial Infections and Mycoses, Dermatomycoses
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT04982159
Bacterial Infections and Mycoses, Dermatomycoses
Córdoba, Spain
View Trial DetailsNCT02984904
Bacterial Infections and Mycoses, Corneal Diseases
View Trial Details